Navigation Links
Study reveals how the world's first drug for amyloid disease works
Date:5/29/2012

LA JOLLA, CA May 29, 2012 Scientists from The Scripps Research Institute and Pfizer Inc. have published a new study showing how a new drug called tafamidis (Vyndaqel) works. Tafamidis, approved for use in Europe and currently under review by the US Food and Drug Administration (FDA), is the first medication approved by a major regulatory agency to treat an amyloid disease, a class of conditions that include Alzheimer's.

Tafamidis treats a deadly nerve disease caused by transthyretin (TTR) amyloid fibril formation, or the accumulation of abnormal assemblies of the TTR protein. The drug inhibits TTR aggregation, and clinical trials have shown that it delays the typical progression of nerve destruction in polyneuropathy patients.

"The details in this new paper, combined with clinical trial data, show for the first time that an amyloid disease can be successfully treated by reducing the rate of amyloid formation," said Jeffery W. Kelly, chair of the Department of Molecular and Experimental Medicine, the Lita Annenberg Hazen Professor of Chemistry, and member of the Skaggs Institute for Chemical Biology at Scripps Research. Kelly is a senior author of the new paper, which appears in an advance, online Early Edition issue of Proceedings of the National Academy of Sciences on May 29, 2012.

An Array of Progressive Symptoms

While the naturally occurring or "wild type" transthyretin protein is prone to aggregate in older people causing cardiac disease, a variety of destabilizing mutations lead either to a primary cardiomyopathy or to early onset forms of polyneuropathy, known as TTR familial amyloid polyneuropathy, affecting about 10,000 people worldwide.

Familial amyloid polyneuropathy compromises the peripheral and autonomic nervous systems, with symptoms including sensory deprivation and pain, muscle weakness and wasting, and alternating constipation and diarrhea. In some familial amyloid polyneuropath
'/>"/>

Contact: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute
Source:Eurekalert  

Page: 1 2 3 4

Related biology news :

1. Study finds emissions from widely used cookstoves vary with use
2. NIH-funded study examines use of mobile technology to improve diet and physical activity behavior
3. Study provides new insights into structure of heart muscle fibers
4. U of M study finds titan cells protect Cryptococcus
5. Variations of a single gene can lead to too much or too little growth, study shows
6. Yale study concludes public apathy over climate change unrelated to science literacy
7. T cells hunt parasites like animal predators seek prey, a Penn Vet-Penn Physics study reveals
8. Study finds voter genetics may predict election outcomes
9. Army study: DNA vaccine and duck eggs protect against hantavirus disease
10. New HealthFocus® International Study Reveals Five Very Different Weight Management Consumers
11. New study shows how nanotechnology can help detect disease earlier
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study reveals how the world's first drug for amyloid disease works
(Date:8/20/2014)... Area Lyme Foundation, which aims to make Lyme disease ... research published in an upcoming issue of the Elsevier ... The findings show that ticks that carry Lyme ... making the threat of Lyme disease year-round. The research ... Health (CDPH) Vector-borne Disease Section and University of California, ...
(Date:8/20/2014)... causes a burning spiciness that is irresistible to some, ... effect are using their findings to develop a new ... be caused by inflammation or other problems. They reported ... in clinical trials, in ACS, Journal of Medicinal ... decades ago, scientists had pegged a compound called capsaicin ...
(Date:8/20/2014)... of honeybees grows to about 4,000 members, it triggers ... building of a special type of comb used for ... from the Department of Neurobiology and Behaviour at Cornell ... reproductive cycle of honeybee colonies. The results are published ... Nature . , Reproduction isn,t always a honeybee ...
Breaking Biology News(10 mins):Lyme disease risk is year-round in Northwest California, according to new study 2Lyme disease risk is year-round in Northwest California, according to new study 3Worker bees 'know' when to invest in their reproductive future 2
... and hunger could be large over the next 20 years, ... higher temperatures could significantly reduce yields of wheat, rice and ... people who subsist on less than $1 a day. The ... and drive many into poverty. But even as some ...
... The old balkanized approach to ocean management, in ... laws and administered by different agencies, has failed to ... a panel of international scientists says, and should be ... planning. The panel, organized by scientists from Duke ...
... biologists and ecologists propose ever-larger conservation areas in the ... it,s local people banding together with their community leaders ... efforts in many parts of the world., "When people ... sacrifice," says Patrick Christie, University of Washington associate professor ...
Cached Biology News:Global warming may hurt some poor populations, benefit others 2Global warming may hurt some poor populations, benefit others 3Global warming may hurt some poor populations, benefit others 4Marine spatial planning: A more balanced approach to ocean management 2Marine spatial planning: A more balanced approach to ocean management 3Marine spatial planning: A more balanced approach to ocean management 4Local social dynamics key to success of tropical marine conservation areas 2
(Date:8/21/2014)... Aug. 21, 2014 OTC Markets ... Inc., a biotechnology company, on its approval to ... traded on OTCQX®, the best marketplace for established ... Group. Logo - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO ... successful execution of its growth strategy and achievement ...
(Date:8/21/2014)... August 21, 2014 Gallus ... contract development and manufacturing organization (CMO) announced today ... Inc., an oncology company focused on the development ... to manufacture the anti-prostate specific membrane antigen (PSMA) ... candidate. Under the agreement the antibody will ...
(Date:8/20/2014)... history lessons often have it that American Indians largely ... chicken pox, influenza and tuberculosis brought to the New ... vary, about 20 million people lived in the Americas ... them were killed by European diseases., But new research ... University and Johannes Krause of the University of Tubingen ...
(Date:8/20/2014)... , Aug. 20, 2014  PAREXEL International Corporation (NASDAQ: ... be presenting at the Baird Healthcare Conference in New ... Chief Financial Officer, will be making a presentation on ... on Wednesday, Sept. 3, 2014. A live ... "Investors" section of PAREXEL,s website at www.PAREXEL.com ...
Breaking Biology Technology:OTC Markets Group Congratulates Immune Pharmaceuticals on NASDAQ Listing 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 3Unusual discovery leads to fascinating tuberculosis theory 2Unusual discovery leads to fascinating tuberculosis theory 3PAREXEL International To Present At Baird Healthcare Conference 2
... China, April 24 /Xinhua-PRNewswire-FirstCall/ -- China Sky One,Medical, ... (OTC Bulletin,Board: CSKI), a pharmaceutical company for external ... ("PRC"), today announced it,acquired Heilongjiang Haina Pharmaceutical Inc. ... laws of the PRC on April,18, 2008., ...
... announced today that Chairman and CEO Fred Hassan purchased,just ... 000 shares at,an average purchase price of $18.26 per ... intention to purchase these shares in,January, this investment in ... -- including ZETIA and VYTORIN --,and our late- stage ...
... 24 /PRNewswire/ - Aegera Therapeutics Inc. is very,pleased ... and,financial executives to its Board of Directors: Mr. ... Managers Limited, and Mr. Gary,Littlejohn, Managing Director of ... experience and networks will be,critical for Aegera as ...
Cached Biology Technology:China Sky One Medical, Inc. Acquires Heilongjiang Haina Pharmaceutical Inc. 2China Sky One Medical, Inc. Acquires Heilongjiang Haina Pharmaceutical Inc. 3Aegera Therapeutics welcomes two experienced executives to its board of directors 2
... Kilo-Sequencing is designed to aid sequence analysis ... multiple cloning sites (MCS) of M13 phage ... vectors (pUC18/19). The kit is used to ... DNA, thereby progressively moving the primer binding ...
Applications: Immunohistochemistry, ISH, FISH, CISH....
Attachments: Clip bar for tubes 10 to 19 mm in diameter Overall Dimension Height IC: 6 (15.2) Overall Dimension Length IC: 18.5 (46.9) Overall Dimension Width IC: 4 (10.2)...
Request Info...
Biology Products: